Coloplast A/S (OTCMKTS:CLPBY) Shares Gap Up – Should You Buy?

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) shares gapped up before the market opened on Wednesday. The stock had previously closed at $6.23, but opened at $6.40. Coloplast A/S shares last traded at $6.38, with a volume of 2,890 shares.

Coloplast A/S Price Performance

The company has a debt-to-equity ratio of 1.51, a current ratio of 1.56 and a quick ratio of 0.94. The business’s fifty day moving average price is $6.73 and its 200-day moving average price is $6.45. The stock has a market capitalization of $14.39 billion, a price-to-earnings ratio of 33.61, a PEG ratio of 2.22 and a beta of 0.21.

Coloplast A/S (OTCMKTS:CLPBY) last released its quarterly earnings results on Tuesday, August 18th. The company reported $0.10 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.10. The business had revenue of $1.14 billion during the quarter, compared to the consensus estimate of $1.11 billion. Coloplast A/S had a return on equity of 39.27% and a net margin of 9.68%. On average, research analysts forecast that Coloplast A/S Sponsored ADR will post 0.4 EPS for the current year.

Coloplast A/S Company Profile

Coloplast A/S is a Denmark-based medical technology company that develops and markets products and services for people with intimate and chronic healthcare needs. Its principal business areas include ostomy care, continence care, wound and skin care, and interventional urology.

The company’s product portfolio includes ostomy bags and accessories, skin-protection products, intermittent catheters, bowel-management systems, and devices used in urological procedures. Recognized brands include SenSura and Brava in ostomy care, SpeediCath in continence care, and Peristeen for bowel management.

Coloplast traces its origins to the 1950s, when nurse Elise Sørensen developed an adhesive ostomy bag to help her sister manage an ileostomy.